Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Final beam laid for new BioEscalator/Novo Nordisk Building, due to open Summer 2018

Image courtesy of Tony Brett

Last week a topping out ceremony was held at the BioEscalator/ Novo Nordisk Building at Old Road Campus to celebrate its final beams being laid. The building will house the Oxford BioEscalator and Novo Nordisk Research Centre Oxford (NNRCO) when it opens in Summer 2018. 

An incredible 15,000 tons of steel work, 3,000 bolts, 5,700 tons of concrete, 423 parking spaces, and 183,000 man hours with no reportable accidents have gone into creating the building and its 2,800mof labspace and offices. 

Elen Wade-Martins, Business Manager for the BioEscalator, and Jim Johnson, Head of the NNRCO, tightened the final bolts on the building and celebrated their vision for the future of the space. 

Novo Nordisk/ Bioescalator topping out

Elen Wade-Martins and Jim Johnson at the Topping Out Ceremony. Photo by David Fleming. 

Elen Wade-Martins commented: 'The BioEscalator will help early stage bioscience companies to overcome obstacles to become sustainable businesses, and enable more of the exciting medical innovation in our labs at the University to make it to the clinic.' 

Jim Johnson expects: 'The new building will be a hub of innovation and collaboration where fundamental biological discoveries are made and translated towards therapeutics for the ultimate benefit of the patients we are dedicated to helping.' 

 

 

Similar stories

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).

National consortium to study threats of new SARS-CoV-2 variants

Coronavirus COVID-19 General Research

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).

Retirement of Professor Peter Brown

General

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

Immunology preprint reviews launched in Nature Reviews Immunology

General Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

No limit to the benefits of exercise in reducing the risk of cardiovascular disease

General Research

A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.’

Accurate predictions of ovarian cancer outcome possible with new classification system

General Research

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.